Does RUXOLITINIB Cause Haemoglobin decreased? 3,297 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,297 reports of Haemoglobin decreased have been filed in association with RUXOLITINIB (OPZELURA). This represents 4.8% of all adverse event reports for RUXOLITINIB.
3,297
Reports of Haemoglobin decreased with RUXOLITINIB
4.8%
of all RUXOLITINIB reports
456
Deaths
1,306
Hospitalizations
How Dangerous Is Haemoglobin decreased From RUXOLITINIB?
Of the 3,297 reports, 456 (13.8%) resulted in death, 1,306 (39.6%) required hospitalization, and 129 (3.9%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 3,297 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
Headache (2,271)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
RIVAROXABAN (1,709)
Which RUXOLITINIB Alternatives Have Lower Haemoglobin decreased Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE